Source: International Congress 2015 – Clinical exercise physiology in health and disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Kreiberg (Copenhagen, Denmark), Michael Kreiberg, Vibeke Backer, Victoria Becker, Sebastian Rzeppa, Peter Hemmersbach, Morten Hostrup. Pharmacokinetics of inhaled terbutaline in relation to doping analysis: Impact of exercise and heat. Eur Respir J 2015; 46: Suppl. 59, 2232

Member's Comments

No comment yet.

Related content which might interest you: Inhaled beta2-agonists increase power development in elite athletes Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Blood and urine response to oral salbutamol during and after intense exercise in elite athletes Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2015 LATE-BREAKING ABSTRACT: The influence of four weeks of beta2-adrenoceptor activation with oral terbutaline on body composition and skeletal muscle contractile properties in active men Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Combined inhalation of beta2-agonists improves supramaximal exercise performance and muscle strength in elite swimmers Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Inhalation of terbutaline increases anaerobic performance and muscle strength in well-trained endurance athletes Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 ERS School Course Basics in Asthma - Exercise testing, exercise-induced asthma and sports Source: ISSN=ISSN 1810-6838, ISBN=, page=163 Year: 2005 Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPD Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Enhancing tolerance to interval exercise in moderate-to-severe COPD Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2 Year: 2014 Cardiorespiratory response to incremental exercise in asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Assessment of respiratory muscle strength in asmathic children: Influence of inhaled corticosteroids Source: Annual Congress 2010 - Advances in lung function from infancy to adolescence Year: 2010 Dynamic hyperinflation and exercise limitation in obese asthmatics Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles Year: 2014 Bronchodilator effect of high strength extrafine BDP/formoterol delivered via NEXThaler® in asthmatics Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Pharmacokinetics (PK) of indacaterol acetate and mometasone furoate delivered alone or in combination following once daily inhalation in healthy subjects Source: International Congress 2014 – Asthma and COPD management Year: 2014 LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Periodized resistence training in COPD: Effects on mucociliary clearance and dyspnea Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD Year: 2015 Single dose pharmacokinetics of C16TR for Inhalation (INS1009) vs treprostinil inhalation solution Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Efficacy and safety of indacaterol acetate on ICS background therapy in asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014